U.S. Advanced Wound Care Market To Reach $4.1 Billion By 2030

U.S. Advanced Wound Care Market Growth & Trends

The U.S. advanced wound care market is expected to reach USD 4.1 billion by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 5.43% over the forecast period. Rising rates of chronic wounds, a rising need for shorter hospital stays, and an increase in the number of surgeries in the U.S. are the major factors contributing to the market growth. The market is also influenced by the growing elderly population, as well as rising rates of obesity, diabetes, chronic diseases, and change in lifestyle.

Products for treating acute and chronic wounds, which include burns, ulcers, and post-operative wounds, are covered in advanced wound care. Hydrogels, hydrocolloids, alginates, film and foam dressings, and other innovative wound care remedies keep the wound moist and encourage the healing process. Advanced wound care assists patients with chronic wounds by offering them readily available, reasonably priced products that they can use whenever convenient. Furthermore, increasing surgical procedures is another important element boosting market growth. Thus, the use of wound care treatments to stop surgical site infections is growing.

Increase in the number of trauma events and accidents, such as RTA, are further expected to fuel market expansion. For instance, according to the Association for Safe International Road Travel, 3,700 individuals lose their lives on the road on average every day, while 1.35 million people die annually in road crashes. Various strategic initiatives undertaken by major market players are further expected to fuel market growth over the forecast period. For instance, in July 2022,  Smith+Nephew announced the launch of the WOUND COMPASS Clinical Support App to help reduce variation in wound care practice. The app is expected to provide digital support to healthcare professionals who aid wound assessment, which helps in decision making & reduced practice variation.

 Request a free sample copy or view report summary: U.S. Advanced Wound Care Market Report

U.S. Advanced Wound Care Market Report Highlights

• Moist dressings dominated the product segment in the market for U.S. advanced wound care in 2022

• Foam dressings segment is expected to grow at a fastest rate during the forecast period, as they are made up of hydrophilic polyurethane material which is a highly absorbent material

• By application, the chronic wounds segment held the largest share in 2022

• Increase in number of chronic wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers is expected to increase the demand for wound care products

• In terms of revenue, the hospitals segment remained the largest proportion of approximately 45% in 2022

• Technological advancements are also anticipated to drive the growth of advanced wound care market

• Few major companies regarding advance wound care include Smith+Nephew, Mölnlycke Health Care AB, ConvaTec Group PLC, Ethicon (Johnson & Johnson), URGO

U.S. Advanced Wound Care Market Segmentation

Grand View Research has segmented the U.S. advance wound care market based on product, application, and end-use:

U.S. Advanced Wound Care Product Outlook (Revenue, USD Million; 2018 - 2030)

• Moist

  • Foam

  • Hydrocolloid

  • Film

  • Alginate

  • Hydrogel

  • Collagen

  • Other Advanced Dressings

• Antimicrobial

  • Silver

  • Non-silver

• Active

  • Biomaterials

  • Skin-substitute

U.S. Advanced Wound Care Application Outlook (Revenue, USD Million; 2018 - 2030)

• Chronic Wounds

  • Diabetic Foot Ulcers

  • Pressure Ulcers

  • Venous Leg Ulcers

  • Others

• Acute Wounds

  • Surgical & Traumatic Wounds

  • Burns

U.S. Advanced Wound Care End-use Outlook (Revenue, USD Million; 2018 - 2030)

• Hospitals

• Specialty Clinics

• Home Healthcare

• Others

List of Key Players in the U.S. Advanced Wound Care Market

• Smith+Nephew

• Mölnlycke Health Care AB

• ConvaTec Group PLC

• Ethicon (Johnson & Johnson)

• URGO

• Coloplast Corp.

• 3M

• Integra LifeSciences

• PAUL HARTMANN AG

• McKesson

• Hydrofera

• Medline Industries, Inc.

• Organogenesis

• Kerecis